SCHEER Agenda of the 12th Plenary meeting | Adoption of the Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices

• Europe

• Medical Devices Risk assessment

1. Welcome and apologies, approval of the agenda and declaration of interests

2. Information from Commission and members of the SCHEER

2.1. Information from the Commission

2.2. Information from the SCHEER members

3. Points for discussion/decision

3.1 For adoption: Opinions

 Final Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices

3.2 For adoption: New mandate(s)

 Revised request for an Opinion on biodegradability of Linear Alkylbenzene Sulphonates (LAS)

3.3. For discussion Emerging issues at the environment-social interface (FORENV)

4. Ongoing work 5. A.O.B.

SOURCE: ec.europa.eu